INTRA-ARTICULAR APPLICATION OF DIFFERENT TYPES OF INJECTIONS IN OSTEOARTHRITIS - LITERATURE REVIEW
Abstract
Osteoarthritis (OA) is a complex, multifactorial disease characterized by an imbalance in chondrocyte metabolism, which ultimately leads to the progressive breakdown of articular cartilage. This process results in chronic pain, joint stiffness, and a decline in overall joint function, severely affecting the patient’s quality of life. OA is one of the most common causes of disability worldwide and frequently affects weight-bearing joints like the knees, hips, and spine. While there is currently no effective cure for OA, treatment strategies are primarily focused on managing pain, alleviating inflammation, and improving joint mobility. The risk factors for developing OA are diverse and include obesity, advancing age, genetic predisposition, and lifestyle factors, such as physical activity levels and previous joint injuries. Diagnosis of OA is typically made through a combination of clinical assessment and imaging studies, with radiographic features such as joint space narrowing, osteophyte formation, and subchondral sclerosis serving as key indicators. Although a variety of treatments, from non-pharmacological interventions to pharmacological therapies and surgical procedures, are utilized, a definitive, long-term cure for OA remains out of reach. As a result, current research is increasingly focused on potential therapies, such as mesenchymal stem cells, hyaluronic acid, corticosteroids, and platelet-rich plasma, which aim to promote cartilage regeneration and repair without significant side effects. This review examines these treatments, evaluating their mechanisms of action, efficacy, safety, and limitations, and highlights current clinical guidelines, as well as the risks associated with their long-term use.
References
Tian R, Su S, Yu Y, et al. Revolutionizing osteoarthritis treatment: How mesenchymal stem cells hold the key. Biomed Pharmacother. 2024;173:116458. doi:10.1016/j.biopha.2024.116458
Giorgino R, Albano D, Fusco S, Peretti GM, Mangiavini L, Messina C. Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update. Int J Mol Sci. 2023;24(7):6405. Published 2023 Mar 29. doi:10.3390/ijms24076405
Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185-199. doi:10.1093/bmb/lds038
Abramoff B, Caldera FE. Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020;104(2):293-311. doi:10.1016/j.mcna.2019.10.007
Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population-Based Survey. Arthritis Care Res (Hoboken). 2016;68(5):574-580. doi:10.1002/acr.22721
Liang H, Suo H, Wang Z, Feng W. Progress in the treatment of osteoarthritis with umbilical cord stem cells. Hum Cell. 2020;33(3):470-475. doi:10.1007/s13577-020-00377-z
Damia E, Chicharro D, Lopez S, et al. Adipose-Derived Mesenchymal Stem Cells: Are They a Good Therapeutic Strategy for Osteoarthritis?. Int J Mol Sci. 2018;19(7):1926. Published 2018 Jun 30. doi:10.3390/ijms19071926
Chen Y, Cheng RJ, Wu Y, Huang D, Li Y, Liu Y. Advances in Stem Cell-Based Therapies in the Treatment of Osteoarthritis. Int J Mol Sci. 2023;25(1):394. Published 2023 Dec 28. doi:10.3390/ijms25010394
Bagge J, Freude K, Lindegaard C, Holst B, Hölmich P. Pros and cons of using autologous versus allogenic stem cells for the treatment of osteoarthritis. Ugeskr Laeger. 2024;186(1):V06230423. Published 2024 Jan 1. doi:10.61409/V06230423
Marinho A, Nunes C, Reis S. Hyaluronic Acid: A Key Ingredient in the Therapy of Inflammation. Biomolecules. 2021;11(10):1518. Published 2021 Oct 15. doi:10.3390/biom11101518
Abatangelo G, Vindigni V, Avruscio G, Pandis L, Brun P. Hyaluronic Acid: Redefining Its Role. Cells. 2020;9(7):1743. Published 2020 Jul 21. doi:10.3390/cells9071743
Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6(7):2397-2404. doi: 10.1096/fasebj.6.7.1563592
Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003;5(2):54-67. doi:10.1186/ar623
DeMoya CD, Joenathan A, Lawson TB, et al. Advances in viscosupplementation and tribosupplementation for early-stage osteoarthritis therapy. Nat Rev Rheumatol. 2024;20(7):432-451. doi:10.1038/s41584-024-01125-5
Peck J, Slovek A, Miro P, et al. A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee. Orthop Rev (Pavia). 2021;13(2):25549. Published 2021 Jul 10. doi:10.52965/001c.25549
Neuman MG, Nanau RM, Oruña-Sanchez L, Coto G. Hyaluronic acid and wound healing. J Pharm Pharm Sci. 2015;18(1):53-60. doi:10.18433/j3k89d
Webner D, Huang Y, Hummer CD 3rd. Intraarticular Hyaluronic Acid Preparations for Knee Osteoarthritis: Are Some Better Than Others?. Cartilage. 2021;13(1_suppl):1619S-1636S. doi:10.1177/19476035211017320
Tang JZ, Nie MJ, Zhao JZ, Zhang GC, Zhang Q, Wang B. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis. J Orthop Surg Res. 2020;15(1):403. Published 2020 Sep 11. doi:10.1186/s13018-020-01919-9
Billesberger LM, Fisher KM, Qadri YJ, Boortz-Marx RL. Procedural Treatments for Knee Osteoarthritis: A Review of Current Injectable Therapies. Pain Res Manag. 2020;2020:3873098. Published 2020 Feb 18. doi:10.1155/2020/3873098
Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021;325(6):568-578. doi:10.1001/jama.2020.22171
Testa G, Giardina SMC, Culmone A, et al. Intra-Articular Injections in Knee Osteoarthritis: A Review of Literature. J Funct Morphol Kinesiol. 2021;6(1):15. Published 2021 Feb 3. doi:10.3390/jfmk6010015
Derwich M, Mitus-Kenig M, Pawlowska E. Mechanisms of Action and Efficacy of Hyaluronic Acid, Corticosteroids and Platelet-Rich Plasma in the Treatment of Temporomandibular Joint Osteoarthritis-A Systematic Review. Int J Mol Sci. 2021;22(14):7405. Published 2021 Jul 9. doi:10.3390/ijms22147405
Mora JC, Przkora R, Cruz-Almeida Y. Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res. 2018;11:2189-2196. Published 2018 Oct 5. doi:10.2147/JPR.S154002
Zhang Y, Chen X, Tong Y, Luo J, Bi Q. Development and Prospect of Intra-Articular Injection in the Treatment of Osteoarthritis: A Review. J Pain Res. 2020;13:1941-1955. Published 2020 Aug 4. doi:10.2147/JPR.S260878
Gibbs AJ, Gray B, Wallis JA, et al. Recommendations for the management of hip and knee osteoarthritis: A systematic review of clinical practice guidelines. Osteoarthritis Cartilage. 2023;31(10):1280-1292. doi:10.1016/j.joca.2023.05.015
Qiao X, Yan L, Feng Y, et al. Efficacy and safety of corticosteroids, hyaluronic acid, and PRP and combination therapy for knee osteoarthritis: a systematic review and network meta-analysis. BMC Musculoskelet Disord. 2023;24(1):926. Published 2023 Nov 30. doi:10.1186/s12891-023-06925-6
Duarte-Monteiro AM, Dourado E, Fonseca JE, Saraiva F. Safety of intra-articular glucocorticoid injections - state of the art. Safety of intra-articular glucocorticoid injections – state of the art. ARP Rheumatol. 2023;2(1):64-73.
Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018;4(1):18-24. doi:10.1159/000477353
Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg. 2002;30(2):97-102. doi:10.1054/jcms.2002.0285
Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review. EFORT Open Rev. 2021;6(4):225-235. Published 2021 Apr 1. doi:10.1302/2058-5241.6.200017
Chen P, Huang L, Ma Y, et al. Intra-articular platelet-rich plasma injection for knee osteoarthritis: a summary of meta-analyses. J Orthop Surg Res. 2019;14(1):385. Published 2019 Nov 27. doi:10.1186/s13018-019-1363-y
Paget LDA, Reurink G, de Vos RJ, et al. Effect of Platelet-Rich Plasma Injections vs Placebo on Ankle Symptoms and Function in Patients With Ankle Osteoarthritis: A Randomized Clinical Trial. JAMA. 2021;326(16):1595-1605. doi:10.1001/jama.2021.16602
Zhuang W, Li T, Li Y, et al. The varying clinical effectiveness of single, three and five intraarticular injections of platelet-rich plasma in knee osteoarthritis. J Orthop Surg Res. 2024;19(1):284. Published 2024 May 8. doi:10.1186/s13018-024-04736-6
Bennell KL, Paterson KL, Metcalf BR, et al. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021;326(20):2021-2030. doi:10.1001/jama.2021.19415
Bansal H, Leon J, Pont JL, et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy [published correction appears in Sci Rep. 2021 Sep 14;11(1):18612. doi: 10.1038/s41598-021-98365-2.]. Sci Rep. 2021;11(1):3971. Published 2021 Feb 17. doi:10.1038/s41598-021-83025-2
Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020;21(20):7794. Published 2020 Oct 21. doi:10.3390/ijms21207794
Romandini I, Boffa A, Di Martino A, et al. Leukocytes Do Not Influence the Safety and Efficacy of Platelet-Rich Plasma Injections for the Treatment of Knee Osteoarthritis: A Double-Blind Randomized Controlled Trial. Am J Sports Med. 2024;52(13):3212-3222. doi:10.1177/03635465241283500
Johal H, Khan M, Yung SP, et al. Impact of Platelet-Rich Plasma Use on Pain in Orthopaedic Surgery: A Systematic Review and Meta-analysis. Sports Health. 2019;11(4):355-366. doi:10.1177/1941738119834972
Nouri F, Babaee M, Peydayesh P, Esmaily H, Raeissadat SA. Comparison between the effects of ultrasound guided intra-articular injections of platelet-rich plasma (PRP), high molecular weight hyaluronic acid, and their combination in hip osteoarthritis: a randomized clinical trial. BMC Musculoskelet Disord. 2022;23(1):856. Published 2022 Sep 12. doi:10.1186/s12891-022-05787-8
Views:
9
Downloads:
2
Copyright (c) 2025 Aleksandra Dzwonkowska, Lidia Jasińska, Marta Bronikowska, Karolina Michalczuk, Paulina Redel, Kamila Prusinowska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
